Canandaigua National Corp’s Gilead Sciences GILD Stock Holding History

Canandaigua National Corp’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$758K	Buy	+5,438	New	+$762K	0.07%	204
2022 Q4	$818K	Buy	9,526 +129	+1%	+$10.2K	0.14%	142
2022 Q3	$580K	Sell	9,397 -90	-0.9%	-$5.67K	0.1%	155
2022 Q2	$586K	Sell	9,487 -1,186	-11%	-$73.4K	0.1%	162
2022 Q1	$635K	Sell	10,673 -113	-1%	-$7.22K	0.1%	171
2021 Q4	$783K	Sell	10,786 -565	-5%	-$38.9K	0.12%	159
2021 Q3	$793K	Sell	11,351 -405	-3%	-$28.5K	0.13%	151
2021 Q2	$810K	Sell	11,756 -87	-0.7%	-$5.81K	0.13%	150
2021 Q1	$765K	Sell	11,843 -24	-0.2%	-$1.55K	0.13%	150
2020 Q4	$691K	Sell	11,867 -384	-3%	-$23.2K	0.12%	148
2020 Q3	$774K	Buy	12,251 +15	+0.1%	+$1.04K	0.14%	147
2020 Q2	$941K	Buy	+12,236	New	+$938K	0.17%	129

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Canandaigua National Corp's GILD Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in Gilead Sciences (GILD) in Q1 2026: 5,438 shares worth $758K. The stake represents 0.07% of the portfolio and ranks #204 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in GILD as recently as Q4 2022.

Canandaigua National Corp first reported a position in GILD in Q2 2020 and has held it in 12 quarters since. The position peaked at $941K in Q2 2020. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Canandaigua National Corp held 5,438 shares of Gilead Sciences worth $758K as of Q1 2026.
Gilead Sciences was a new Canandaigua National Corp position in Q1 2026.
Gilead Sciences made up 0.07% of Canandaigua National Corp's portfolio in Q1 2026, its #204 holding.
Canandaigua National Corp first reported a position in Gilead Sciences in Q2 2020 and has held it in 12 quarters since.
Canandaigua National Corp's Gilead Sciences position peaked at $941K in Q2 2020.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.